Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
Immunological aspects of cancer chemotherapy
2007
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
EGFR Antagonists in Cancer Treatment
2008 Standout
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
2002 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention
2004
Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction
1995
Cancer Metastasis: Building a Framework
2006 Standout
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
2010
Lung Cancer
2008 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Signaling Pathways Leading to Transcription and Translation Cooperatively Regulate the Transient Increase in Expression of c-Fos Protein
2001 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
2002
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
2011
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
Wnt/β-Catenin Signaling and Disease
2012 Standout
Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway
1998 StandoutNobel
The microenvironment of the tumour–host interface
2001 StandoutNature
Immunity, Inflammation, and Cancer
2010 Standout
Expression and phosphorylation of rat c-met/hepatocyte growth factor receptor during rat liver regeneration
1995
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
1998 Standout
Protein modules and signalling networks
1995 StandoutNature
Emerging Biological Principles of Metastasis
2017 Standout
Peptide growth factors in the intestine
2001
Hypoxic gene expression and metastasis
2004
EMT: 2016
2016 Standout
A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
1994
Cancer immunotherapy comes of age
2011 StandoutNature
Series Introduction: Invasive growth: from development to metastasis
2002
Hypoxia-driven selection of the metastatic phenotype
2007
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
Expression of CD44 in Apc and TcfMutant Mice Implies Regulation by the WNT Pathway
1999
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
2008
The basics of epithelial-mesenchymal transition
2009 Standout
Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.
1995
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
2012 Nature
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor
1995
Transformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
1994 StandoutScience
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer
1999
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
2003
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
2009 StandoutNature
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
Cancer of the Ovary
2004 Standout
The multiple roles of tumour stroma
1997
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
2004 StandoutScience
Life with Oxygen
2007 StandoutScienceNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
2000 StandoutNobel
Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.
2001
Oncogenic Mutants of RON and MET Receptor Tyrosine Kinases Cause Activation of the β-Catenin Pathway
2001
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
The Met pathway: master switch and drug target in cancer progression
2006
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
Integrins and Signal Transduction Pathways: the Road Taken
1995 StandoutScience
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.
2003
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
2003
Liver Regeneration
1997 StandoutScience
Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells.
1994
The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade.
1993
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
1992
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
2005
Different point mutations in the met oncogene elicit distinct biological properties
2000
Radiation to Stromal Fibroblasts Increases Invasiveness of Pancreatic Cancer Cells through Tumor-Stromal Interactions
2004
Works of S. Bretti being referenced
Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma
2001
Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients
1996
Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.
1995
Expression of the Met/HGF receptor in normal and neoplastic human tissues.
1991